Your fact-checks will appear here
When a ’s name is used without authorization on supplement packaging, several legal paths exist: statutory claims under the for false endorsement, state “” actions (often yielding actual damages and d...
Since 2023 regulators and plaintiffs have continued to press memory‑enhancing supplement makers through warning letters, court orders, and class actions: notable actions include FDA warning letters to...
There is clear public criticism of DrAxe/draxe.com documented by Truth in Advertising (TINA.org) and media watchdogs, but the sources provided do not show that TINA.org or other named consumer groups ...